Chauncey W. Crandall, M.D., F.A.C.C.

Dr. Chauncey W. Crandall, author of Dr. Crandall’s Heart Health Report newsletter, is chief of the Cardiac Transplant Program at the world-renowned Palm Beach Cardiovascular Clinic in Palm Beach Gardens, Fla. He practices interventional, vascular, and transplant cardiology. Dr. Crandall received his post-graduate training at Yale University School of Medicine, where he also completed three years of research in the Cardiovascular Surgery Division. Dr. Crandall regularly lectures nationally and internationally on preventive cardiology, cardiology healthcare of the elderly, healing, interventional cardiology, and heart transplants. Known as the “Christian physician,” Dr. Crandall has been heralded for his values and message of hope to all his heart patients.

Tags: cholesterol | nucleotide | genetic | heart disease
OPINION

Genetic Test for Heart Disease

Chauncey Crandall, M.D. By Monday, 24 September 2018 04:44 PM EDT Current | Bio | Archive

Doctors are coming closer to an innovation that could make a huge difference in heart disease diagnosis — a genetic test for heart disease that would allow those at risk to jump-start intervention strategies.

Currently, lifestyle is used as a predictor, with factors such as cholesterol, blood pressure, habits like smoking, and medical history taken into account.

But because so much of heart disease is considered inherited, a genetic test is the key to all sorts of predictions.

If we could do this, we could potentially determine who should be targeted for interventions much earlier in life.

At the University of Melbourne’s Centre for Systems Genomics in Australia, scientists have developed exactly that type of risk score as a predictor.

Their score is based on more than 49,000 single nucleotide polymorphisms — SNPs — single letters in the human genome sequence that can vary for individuals.

Their results signal a breakthrough for genetic heart disease prediction.

© 2024 NewsmaxHealth. All rights reserved.


Dr-Crandall
Doctors are coming closer to an innovation that could make a huge difference in heart disease diagnosis — a genetic test that would allow those at risk to jump-start intervention strategies.
cholesterol, nucleotide, genetic, heart disease
153
2018-44-24
Monday, 24 September 2018 04:44 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved